The associations between the environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer risk and progression

Science China Chemistry

Volumn 53, Issue 5, 2010, Pages 974-979

  Liu, SiJin ^a   Zhang, ShuPing ^a   Qu, Chen ^a   Liu, Wei ^a   Du, YuGuo ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

Author keywords

Breast cancer risk; CYP1A1 polymorphisms; Environmental exposure; Polychlorinated biphenyls (PCBs); Tumor progression

Indexed keywords

BREAST CANCER; BREAST CANCER RISK; CHLORINATED BIPHENYLS; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC-STUDY; ETIOLOGIC AGENTS; HUMAN HEALTH; IN-VIVO; MAMMARY TISSUE; POTENTIAL THREATS; TUMOR PROGRESSIONS;

HEALTH RISKS; POLYMORPHISM; TUMORS;

POLYCHLORINATED BIPHENYLS;

EID: 77953455145     PISSN: 16747291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-010-0149-1     Document Type: Review

References (52)

1. DeCaprio AP, Johnson GW, Tarbell AM, Carpenter DO, Chiarenzelli JR, Morse GS, Santiago-Rivera AL, Schymura MJ. Polychlorinated biphenyl (PCB) exposure assessment by multivariate statistical analysis of serum congener profiles in an adult Native American population. Environ Res, 2005, 98:284-302
2. Park JS, Linderholm L, Charles MJ, Athanasiadou M, Petrik J, Kocan A, Drobna B, Trnovec T, Bergman A, Hertz-Picciotto I. Polychlorinated biphenyls and their hydroxylated metabolites (OH-PCBS) in pregnant women from eastern Slovakia. Environ Health Perspect, 2007, 115:20-27
3. Humphrey HE, Gardiner JC, Pandya JR, Sweeney AM, Gasior DM, McCaffrey RJ, Schantz SL. PCB congener profile in the serum of humans consuming Great Lakes fish. Environ Health Perspect, 2000, 108:167-172
4. Selgrade MK. Immunotoxicity: the risk is real. Toxicol Sci, 2007, 100:328-332
5. Carpenter DO. Polychlorinated biphenyls (PCBs) : routes of exposure and effects on human health. Rev Environ Health, 2006, 21:1-23
6. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103 Suppl, 1995, 7:113-122
7. Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptorbinding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Mol Pharmacol, 1988, 33:120-126
8. Prins GS. Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer, 2008, 15:649-656
9. Golden R, Kimbrough R. Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003. Crit Rev Toxicol, 2009, 39:299-331
10. Faroon OM, Keith S, Jones D, De Rosa C. Carcinogenic effects of polychlorinated biphenyls. Toxicol Ind Health, 2001, 17:41-62
11. Salehi F, Turner MC, Phillips KP, Wigle DT, Krewski D, Aronson KJ. Review of the etiology of breast cancer with special attention to organochlorines as potential endocrine disruptors. J Toxicol Environ Health B Crit Rev, 2008, 11:276-300
12. Calle EE, Frumkin H, Henley SJ, Savitz DA, Thun MJ. Organochlorines and breast cancer risk. CA Cancer J Clin, 2002, 52:301-309
13. Millikan R, DeVoto E, Duell EJ, Tse CK, Savitz DA, Beach J, Ed-miston S, Jackson S, Newman B. Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev, 2000, 9:1233-1240
14. Holford TR, Zheng T, Mayne ST, Zahm SH, Tessari JD, Boyle P. Joint effects of nine polychlorinated biphenyl (PCB) congeners on breast cancer risk. Int J Epidemiol, 2000, 29:975-982
15. Shiraishi F, Okumura T, Nomachi M, Serizawa S, Nishikawa J, Edmonds JS, Shiraishi H, Morita M. Estrogenic and thyroid hormone activity of a series of hydroxypolychlorinated biphenyls. Chemosphere, 2003, 52:33-42
16. Negri E, Bosetti C, Fattore E, La Vecchia C. Environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer: a systematic review of the epidemiological evidence. Eur J Cancer Prev, 2003, 12:509-516
17. Bonefeld-Jorgensen EC, Andersen HR, Rasmussen TH, Vinggaard AM. Effect of highly bioaccumulated polychlorinated biphenyl congeners on estrogen and androgen receptor activity. Toxicology, 2001, 158:141-153
18. Fossi MC, Massi A, Lari L, Marsili L, Focardi S, Leonzio C, Renzoni A. Interspecies differences in mixed function oxidase activity in birds: Relationship between feeding habits, detoxication activities and organochlorine accumulation. Environ Pollut, 1995, 90:15-24
19. Safe S. Endocrine disruptors and human health: is there a problem. Toxicology, 2004, 205:3-10
20. Arnold SF, Klotz DM, Collins BM, Vonier PM, Jr Guillette LJ, McLachlan JA. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science, 1996, 272:1489-1492
21. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect, 1993, 101:372-377
22. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst, 1993, 85:648-652 (Pubitemid 23120510)
23. Dewailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin J, Brisson J. High organochlorine body burden in women with estrogen receptorpositive breast cancer. J Natl Cancer Inst, 1994, 86:232-234
24. Hopf NB, Ruder AM, Succop P. Background levels of polychlorinated biphenyls in the U. S. population. Sci Total Environ, 2009, 407:6109-6119
25. Lorber M, Patterson D, Huwe J, Kahn H. Evaluation of background exposures of Americans to dioxin-like compounds in the 1990s and the 2000s. Chemosphere, 2009, 77:640-651
26. Zhao XR, Qin ZF, Yang ZZ, Zhao Q, Zhao YX, Qin XF, Zhang YC, Ruan XL, Zhang YF, Xu XB. Dual body burdens of polychlorinated biphenyls and polybrominated diphenyl ethers among local residents in an e-waste recycling region in Southeast China. Chemosphere, 2010, 78:659-666
27. Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis. Am J Epidemiol, 2002, 155:629-635
28. Liljegren G, Hardell L, Lindstrom G, Dahl P, Magnuson A. Case-control study on breast cancer and adipose tissue concentrations of congener specific polychlorinated biphenyls, DDE and hexa-chlorobenzene. Eur J Cancer Prev, 1998, 7:135-140
29. Aronson KJ, Miller AB, Woolcott CG, Sterns EE, McCready DR, Lickley LA, Fish EB, Hiraki GY, Holloway C, Ross T, Hanna WM, SenGupta SK, Weber JP. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 2000, 9:55-63
30. Rusiecki JA, Holford TR, Zahm SH, Zheng T. Polychlorinated biphenyls and breast cancer risk by combined estrogen and progester-one receptor status. Eur J Epidemiol, 2004, 19:793-801
31. Muscat JE, Britton JA, Djordjevic MV, Citron ML, Kemeny M, Busch-Devereaux E, Pittman B, Stellman SD. Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev, 2003, 12:1474-1478
32. Zhang ZY, Fasco MJ, Huang L, Guengerich FP, Kaminsky LS. Characterization of purified human recombinant cytochrome P4501A1-Ile462 and-Val462: assessment of a role for the rare allele in carcinogenesis. Cancer Res, 1996, 56:3926-3933
33. Cosma G, Crofts F, Taioli E, Toniolo P, Garte S. Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health, 1993 40:309-316
34. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett, 1990, 263:131-133
35. Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S, Ambrosone CB. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev, 1999, 8:41-44
36. Laden F, Ishibe N, Hankinson SE, Wolff MS, Gertig DM, Hunter DJ, Kelsey KT. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses[2032] Health Study. Cancer Epidemiol Biomarkers Prev, 2002, 11:1560-1565
37. Zhang Y, Wise JP, Holford TR, Xie H, Boyle P, Zahm SH, Rusiecki J, Zou K, Zhang B, Zhu Y, Owens PH, Zheng T. Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol, 2004, 160:1177-1183
38. Li Y, Millikan RC, Bell DA, Cui L, Tse CK, Newman B, Conway K. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res, 2004, 6: R460-R473
39. Agundez JA. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab, 2004, 5:211-224
40. Li Y, Millikan RC, Bell DA, Cui L, Tse CK, Newman B, Conway K. Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study. Breast Cancer Res, 2005, 7: R12-18
41. Masson LF, Sharp L, Cotton SC, Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol, 2005, 161:901-915
42. Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev, 2000, 9:161-166
43. Snedeker SM. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect 109 Suppl, 2001, 1:35-47
44. Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE, Miller AB. Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Con-trol, 2001, 12:395-404
45. Tang Y, Olufemi L, Wang MT, Nie D. Role of Rho GTPases in breast cancer. Front Biosci, 2008, 13:759-776
46. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol, 2003, 4:446-456
47. Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW. Rho-kinase (ROK) promotes CD44v (3, 8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton, 1999, 43:269-287
48. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med, 1999, 5:221-225
49. Li B, Zhao WD, Tan ZM, Fang WG, Zhu L, Chen YH. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett, 2006, 580:4252-4260
50. Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E. ROCK -and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol, 2006, 16:1515-1523
51. Liu S, Goldstein RH, Scepansky EM, Rosenblatt M. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res, 2009, 69:8742-8751
52. Gammon MD, Wolff MS, Neugut AI, Terry MB, Britton JA, Greenebaum E, Hibshoosh H, Levin B, Wang Q, Santella RM. Treatment for breast cancer and blood levels of chlorinated hydrocarbons. Cancer Epidemiol Biomarkers Prev, 1996, 5:467-471